83 participants
A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-13
- Start Date:
- 2024-06-19
- Completion:
- 2026-12-31
Conditions
- HER2-positive Breast Cancer
Interventions
- DRUG
No Results Yet